Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
All >

News > Southern Europe & Israel

Please find below news about Albania, Bosnia and Herzegovina, Croatia, Greece, Israel, Italy, Malta, Montenegro, Portugal, Macedonia, Serbia, Slovenia, Spain and Turkey as well as about organisations from these countries.

Total search results: 368 | Ordered by Date (descending)
1 2 3 4  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
DiaSorin S.p.A.. (4/11/21). "Press Release: DiaSorin to Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion". Saluggia. 2021-04-11
Inbrain Neuroelectronics S.L.. (3/26/21). "Press Release: Inbrain Neuroelectronics Raises Over €14M Series A". Barcelona. 2021-03-26
Advent France Biotechnology S.A.S.. (3/17/21). "Press Release: Advent France Biotechnology Appoints Alejo Chorny, PhD, as Operating Partner and Head of New Spanish Operations". Paris & Barcelona. 2021-03-17
Almirall S.A.. (2/17/21). "Press Release: Almirall and MC2 Therapeutics Enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora Cream for Treatment of Plaque Psoriasis". Barcelona & Copenhagen. 2021-02-17
ERS Genomics Ltd.. (2/16/21). "Press Release: ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement". Dublin & Barcelona. 2021-02-16
Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". 2021-02-03
Enthera S.r.l.. (1/28/21). "Press Release: Enthera Pharmaceuticals Extends Series A Financing, Raising a Total of €35 million". Milan. 2021-01-28
2cureX AB. (1/28/21). "Press Release: 2cureX Appoints Kenneth Graabek Johansen, an Experienced Business and Financial Executive, as New CFO". Copenhagen. 2021-01-28
Minoryx Therapeutics S.L.. (1/26/21). "Press Release: Minoryx Presents Topline Results from Phase 2/3 »ADVANCE« Study Demonstrating Significant Clinical Benefit of Leriglitazone in Adrenomyeloneuropathy (AMN)". Mataró, Barcelona. 2021-01-26
Sophia Genetics S.A.. (1/19/21). "Press Release: Sophia Genetics and the Spanish Lung Cancer Group Team Up to Explore the Predictive Potential of Multimodal Health Data in Resectable Stage IIIA Non-Small Cell Lung Cancer". Boston, MA & Lausanne. 2021-01-19
Moderna, Inc.. (1/4/21). "Press Release: Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel". Cambridge, MA. 2021-01-04
Arvelle Therapeutics GmbH. (1/4/21). "Press Release: Angelini Pharma Acquires Arvelle Therapeutics to Create a Leading European Innovator in Central Nervous System (CNS) and Mental Health Disorder Treatments". Rome. 2021-01-04
Peptilogics. (12/21/20). "Press Release: Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform". Pittsburgh, PA. 2020-12-21
Atomwise, Inc.. (12/18/20). "Press Release: Atomwise and FutuRx Launch A2i Therapeutics – a New Immuno-Oncology Company Funded by Leading Biopharma VCs and the Israeli Innovation Authority". San Francisco, CA & Ness Ziona. 2020-12-18
MagForce AG. (12/15/20). "Press Release: MagForce AG Successfully Completes Private Placement of New Shares". Berlin & Nevada. 2020-12-15
Valo Health LLC. (12/9/20). "Press Release: Valo Health Expands Global Operations With Key Leadership in Tel Aviv". Boston, MA. 2020-12-09
Enthera S.r.l.. (12/3/20). "Press Release: Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development". Milan. 2020-12-03
Kaia Health Software GmbH. (11/30/20). "Press Release: Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets". Munich & Parma. 2020-11-30
Grifols S.A.. (11/24/20). "Press Release: Strategic Alliance between Grifols and the Egyptian Government to Boost Plasma-derived Medicines Self-sufficiency in the Middle East and Africa". Barcelona. 2020-11-24
Galapagos N.V.. (11/23/20). "Press Release: Selvita to Acquire Fidelta from Galapagos". Mechelen & Krakow. 2020-11-23
Atai Life Sciences AG. (11/23/20). "Press Release: Atai Life Sciences Announces Closing of $125 Million Series C Financing Round". New York, NY. 2020-11-23
InSilicoTrials. (10/7/20). "Press Release: Blog Post – United Venture Is the Lead Investor in Our Round A". 2020-10-07
Sartorius AG. (10/2/20). "Press Release: Purification Specialist BIA Separations to Become Part of Sartorius". Göttingen. 2020-10-02
High-Tech Gründerfonds Management GmbH. (10/1/20). "Press Release: Neuromodulation Pioneer Wise Closes EUR 15M Series C Financing Round to Launch Second Product, SCS EXPERT, for Chronic Pain". 2020-10-01
Kymos S.L.. (9/28/20). "Press Release: Kymos and Prolytic Merge to Become Kymos Group". Barcelona & Frankfurt a.M.. 2020-09-28
Salvia BioElectronics B.V.. (9/22/20). "Press Release: Salvia BioElectronics Raises EUR 26M (USD 31M) to Develop Innovative Neurostimulation Therapy for Chronic Migraine". Eindhoven. 2020-09-22
Lonza Group Ltd.. (9/8/20). "Press Release: Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform". Basel & Tel Aviv. 2020-09-08
Algenex S.L.. (9/8/20). "Press Release: Algenex Raises €7.4 Million in Financing Round". Madrid. 2020-09-08
Grifols S.A.. (9/7/20). "Press Release: Grifols to Acquire Alkahest to Enhance Discovery Research and Development". Barcelona & San Carlos, CA. 2020-09-07
Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan. 2020-07-30
Enthera S.r.l.. (7/28/20). "Press Release: Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease". Milan. 2020-07-28
Coulter Partners. (7/28/20). "Press Release: Coulter Partners Secures Chief Executive Officer for Optimapharm". 2020-07-28
Optimapharm d.d.. (7/21/20). "Press Release: Optimapharm Appoints Dr. Andrew Copestake as Chief Executive Officer". 2020-07-21
Moderna, Inc.. (7/9/20). "Press Release: Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate". Cambridge, MA & Madrid. 2020-07-09
VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. 2020-07-08
BIA Separations d.o.o.. (7/8/20). "Press Release: BIA Separations Signs Two New Distribution Agreements Extending Coverage in Asia Pacific". Ajdovšcina. 2020-07-08
Genespire S.r.l.. (6/30/20). "Press Release: Genespire and the San Raffaele Telethon Institute for Gene Therapy Announce Publication in Nature Biotechnology on Enhanced Gene Editing Technique in Hematopoietic Stem Cells". Milan. 2020-06-30
Ona Therapeutics. (6/16/20). "Press Release: Ona Therapeutics Raises €30m in Series A Financing". Barcelona. 2020-06-16
Epsilen Bio S.r.l.. (6/15/20). "Press Release: Epsilen Bio Appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board. Company Announces Strategic Collaboration with SR-Tiget". Milan. 2020-06-15
Catalan Institute of Nanoscience and Nanotechnology (ICN2(. (6/11/20). "Press Release: New Investors for Inbrain to Develop Graphene-based Implants against Brain Disorders". 2020-06-11
Ysios Capital. (6/10/20). "Press Release: Ysios Capital Presents Its Third Fund of € 200M". San Sebastián & Barcelona. 2020-06-10
Rigenerand S.r.l.. (6/2/20). "Press Release: Rigenerand Receives Regulatory Approval for Gene Therapy Production". Modena. 2020-06-02
Accure Therapeutics. (5/26/20). "Press Release: Accure Therapeutics Launches with €7.6M Series A Round". Barcelona. 2020-05-26
Genespire S.r.l.. (5/13/20). "Press Release: Genespire and SR-Tiget Announce Strategic Alliance for the Development of Transformative Gene Therapies for Genetic Diseases and Disclose Collaboration Focus". Milan. 2020-05-13
TRG Management LLP. (5/12/20). "Press Release: The Rohatyn Group Completes Investment in European Contract Research Organization, Optimapharm". New York, NY. 2020-05-12
ElsaLys Biotech S.A.S.. (5/7/20). "Press Release: Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies". Milan. 2020-05-07
PinCell S.r.l.. (5/6/20). "Press Release: PinCell Appoints Veteran Biotech and Biopharma Executives to Management Team and Board of Directors. The Nominations Follow a Successful Seed Funding Led by Sofinnova Partners". Milan. 2020-05-06
Stemline Therapeutics, Inc.. (5/4/20). "Press Release: Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million". Florence & New York, NY. 2020-05-04
Genespire S.r.l.. (4/29/20). "Press Release: Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies. Biotech Executive, Julia Berretta, Ph.D., Is Named Chief Executive Officer". Milan. 2020-04-29
Sofinnova Partners. (4/20/20). "Press Release: Sofinnova Partners Announces Third Investment from its Italian Fund". Milan. 2020-04-20
LNC Therapeutics. (4/15/20). "Press Release: LNC Therapeutics Announces the Acquisition of an Exclusive Worldwide Licence on the First Patent related to Christensenella’s Therapeutic Applications in Mood Disorders". Bordeaux. 2020-04-15
MolMed S.p.A.. (4/14/20). "Press Release: MolMed: the Board of Directors, Based on the Scientific Evidence from the Experiments on Early-stage Pre-clinical Products, Decided to Suspend the Investments in These Projects". Milan. 2020-04-14
Izana Bioscience Ltd.. (4/6/20). "Press Release: Initiation of Two-centre Compassionate Use Study Involving Namilumab in the Treatment of Individual Patients with Rapidly Worsening COVID-19 Infection in Italy". Oxford. 2020-04-06
ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. 2020-04-02
MolMed S.p.A. (at the request of AGC Inc.). (4/2/20). "Press Release: Offer Document Filed with Consob. Voluntary Public Tender Offer Launched by AGC Inc. on All the Ordinary Shares of MolMed S.p.A. [Not for release where violation of laws or regulations 2020-04-02
Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. 2020-03-27
AGC Inc.. (3/17/20). "Press Release: AGC Decides to Launch Voluntary Tender Offer for Shares of MolMed". 2020-03-17
MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. 2020-03-09
MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan. 2020-03-06
BIA Separations d.o.o.. (2/19/20). "Press Release: BIA Separations and University of Zagreb Sign License Agreement to Commercialize Novel Elution Method for Virus and Viral Vector purification". Ajdovšcina & zagreb. 2020-02-19
Grifols S.A.. (2/18/20). "Press Release: Grifols and the Public Investment Fund of Saudi Arabia Taking Steps to Boost Plasma Medicines Self-supply in the Region". Barcelona. 2020-02-18
PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. 2020-02-17
Aurora-TT S.r.l.. (2/12/20). "Press Release: Rottapharm Biotech and Italfarmaco Team Up with AurorA-TT to launch AurorA Science". Milano. 2020-02-12
Osteolabs GmbH. (1/20/20). "Press Release: Osteolabs GmbH Successfully Closes First International Commercial Agreements and Starts Contract Research Collaboration with the Health Department of an European Army". Kiel. 2020-01-20
Almirall S.A.. (1/9/20). "Press Release: Almirall Signs a Strategic Agreement with 23andMe to License Rights of a Bispecific Monoclonal Antibody that Blocks All Three Isoforms of IL-36 Cytokine". Barcelona & Sunnyvale, CA. 2020-01-09
Almirall S.A.. (1/9/20). "Press Release: Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases". Barcelona. 2020-01-09
Almirall S.A.. (1/9/20). "Press Release: Almirall Enters into an Option Agreement to Acquire Bioniz Therapeutics and to Establish a Broad Research Agreement to Further Expand Its Innovative Pipeline in Medical Dermatology". Barcelona. 2020-01-09
Esteve Pharmaceuticals, S.A.. (1/8/20). "Press Release: Esteve Acquires German Proprietary, Specialty, Hospital-focused Company Riemser and Expands Its Presence in Europe". 2020-01-08
MolMed S.p.A.. (12/18/19). "Press Release: Italy – the EIB Supports MolMed Investment in Research, Development and Manufacturing for Cancer and Rare Diseases Innovative Treatments". Oxford. 2019-12-18
Bioncotech Therapeutics S.L.. (12/12/19). "Press Release: Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress 2019". Madrid. 2019-12-12
Bioncotech Therapeutics S.L.. (12/10/19). "Press Release: Bioncotech Therapeutics Announces Oncology Clinical Trial Collaboration with MSD. Phase II Trial with Combination of BO-112 and Pembrolizumab". Madrid. 2019-12-10
Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. 2019-11-27
Parc Cientific de Barcelona (BCP, Barcelona Science Park Foundation). (10/28/19). "Press Release: Molomics Opens an Investment Round to Accelerate an Innovative Project against Parkinson’s". Planegg & Mechelen. 2019-10-28
SP Industries, Inc.. (10/28/19). "Press Release: SP Acquires Spain Based i-Dositecno". Warminster, PA. 2019-10-28
Evotec SE. (10/23/19). "Press Release: Evotec, Integra Holdings and Yissum Establish LAB555 to Fast Track Early-stage Drug Development". Hamburg. 2019-10-23
Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. 2019-10-22
Biocat. (10/21/19). "Press Release: Boehringer Ingelheim Joins the d·HEALTH Barcelona Program to Foster Innovation in Health". Barcelona. 2019-10-21
MolMed S.p.A.. (10/10/19). "Press Release: MolMed Informs on Its Decision to Withdraw the Conditional Marketing Authorization of Zalmoxis". Milan. 2019-10-10
Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire. 2019-09-30
Innate Pharma S.A.. (9/23/19). "Press Release: Innate Pharma Announces Clinical Data Presentations on IPH5401 and Monalizumab at ESMO 2019". Marseille. 2019-09-23
Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan. 2019-09-20
CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. 2019-09-17
Genenta Science S.r.l.. (9/11/19). "Press Release: Genenta Science Announces 13.2 Million in a New Round of Financing, Hits a Total above 30 Million since Inception. Two Clinical Trials Ongoing.". Milano & New York, NY. 2019-09-11
Devicare S.L.. (9/5/19). "Press Release: The PREVENTLIT Study Shows that Lit-Control Reduces new Episodes of Renal Lithiasis in Patients". Cerdanyola del Vallès. 2019-09-05
Bruker Corporation. (8/26/19). "Press Release: Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data". Berlin. 2019-08-26
SP Industries, Inc.. (8/13/19). "Press Release: SP Scientific Announces the Signing of New Partnership Agreement ith Lab-i-Dositecno Pharma Technologies". Warminster, PA. 2019-08-13
Grifols S.A.. (7/31/19). "Press Release: Grifols Increases Its Revenues by 14.3% to EUR 2,423 million, Driven by Its Strategic Growth Plan". Barcelona. 2019-07-31
Curetis N.V.. (7/30/19). "Press Release: Curetis and Ako Med Ink Distribution Agreement Covering Four Countries in CEE Region". Amsterdam, San Diego, CA & Holzgerlingen. 2019-07-30
Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. 2019-07-25
Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris. 2019-07-23
3P Biopharmaceuticals S.L.. (7/23/19). "Press Release: 3P Biopharmaceuticals Welcomes Keensight Capital as Majority Shareholder". Paris. 2019-07-23
ImCheck Therapeutics S.A.S.. (7/18/19). "Press Release: ImCheck Therapeutics Appoints Paul Frohna MD, PhD, PharmD, as Chief Medical Officer". Marseille. 2019-07-18
Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid. 2019-07-16
Kither Biotech S.r.l.. (7/5/19). "Press Release: Kither Biotech Raises a €5.6m Financing Round to Support the Clinical Development of a New Drug for Cystic Fibrosis and other Pulmonary Diseases". Turin. 2019-07-05
Illumina, Inc.. (6/28/19). "Press Release: Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US". San Diego, CA. 2019-06-28
Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. 2019-06-26
Catalent, Inc.. (6/19/19). "Press Release: Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy". New York, NY & Somerset, NJ. 2019-06-19
Qiagen N.V.. (6/5/19). "Press Release: Qiagen and DiaSorin Collaborate on Novel QuantiFERON-based Test with Breakthrough Potential for Earlier Detection of Lyme Disease". Germantown, MD, Hilden & Saluggia. 2019-06-05
Spindiag GmbH. (6/4/19). "Press Release: Spindiag’s Continued Road to Success. Expansion of Series A with an additional 4 Million Euros for Market Entry". Freiburg. 2019-06-04
Galapagos N.V.. (5/29/19). "Press Release: Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)". Foster City, CA & Mechelen. 2019-05-29
1 2 3 4  next pagenext page



Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px

» top